Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study.

In contrast, strong and highly significant correlations were observed in the combined golimumab group between baseline CRP levels and baseline ASspiMRI-a scores and between baseline CRP levels and changes from baseline to weeks 14 and 104 in ASspiMRI-a scores ( table 4 ), such that higher baseline CRP levels were associated with higher baseline ASspiMRI-a scores and with greater improvement in ASspiMRI-a scores from baseline to weeks 14 and 104.

also in 132,142 other papers